Publications by authors named "Kazuya Akaji"
Mod Rheumatol
August 2024
Article Synopsis
- The study investigates long-term retention rates of biologic treatments for psoriatic arthritis, finding retention rates of about 70% for adalimumab, 50% for ixekizumab, and 40% for secukinumab after 10 years.
- It analyzes 146 prescriptions from a hospital since March 2010, focusing on why patients discontinued their treatments, with secondary inefficacy being the main reason for discontinuation.
- A notable finding was that the severity of arthritis at the start of adalimumab treatment was associated with higher chances of it becoming ineffective over time.
